Zhou, Xianjin https://orcid.org/0000-0002-2994-1571
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NIH R01NS135620)
Article History
Received: 28 April 2025
Revised: 15 December 2025
Accepted: 28 January 2026
First Online: 5 February 2026
Competing interests
: XZ is the inventor on a provisional patent filing “Therapeutic Autoantibodies (UCSD Ref. No. SD2023–130)” by the University of California San Diego.
: EDTA plasma samples from Alzheimer’s disease patients and healthy controls were received from Alzheimer’s Disease Research Center (ADRC) at University of California San Diego (UCSD). The original collection of those samples was performed under a protocol approved by the UCSD Human Research Protections Program (IRB Protocol 170957).